UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling

Cancer Research - United States
doi 10.1158/0008-5472.can-18-1040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Temporal Activation of WNT/β-catenin Signaling Is Sufficient to Inhibit SOX10 Expression and Block Melanoma Growth

Oncogene
Cancer ResearchGeneticsMolecular Biology
2020English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery
Oncology
2017English

SCF Promotes the Production of IL‑13 via the MEK‑ERK‑CREB Signaling Pathway in Mast Cells

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Frontiers in Oncology
Cancer ResearchOncology
2015English

Sonic Hedgehog Signaling Pathway Promotes Pancreatic Cancer Pain via Nerve Growth Factor

Regional Anesthesia and Pain Medicine
MedicineAnesthesiologyPain Medicine
2019English

UBE2N Plays a Pivotal Role in Maintaining Melanoma Malignancy

Oncotarget
Oncology
2018English

NKAP Alters Tumor Immune Microenvironment and Promotes Glioma Growth via Notch1 Signaling

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

930 SOX2 Epidermal Overexpression Promotes Cutaneous Wound Healing via Activation of EGFR/MEK/ERK Signaling Mediated by EGFR Ligands

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

RAB22A Overexpression Promotes the Tumor Growth of Melanoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy